does orforglipron actually matter or is it forum lore at this point
I have had 9 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 18 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 97.9% against a claimed 94.2%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
Half-life is about 168 hours, so steady state lands around week 24–5. Practical consequence: what you feel in week 1 is not what that dose does.
Not convinced. The evidence does not support that reading.
Second this question. I have wondered about orforglipron for 23 months and never seen a straight answer.
I am going to push back on this slightly.
Retitled to remove editorialising. Put the evidence in the body.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
the absorption problem is solved by non-peptide structure
Came off after 95 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.
This is correct. ATTAIN data is phase 13.
availability speculation must be flaired Speculation
What was the batch number and which service?
the nausea profile is speculative at this stage
phase 22 data is interesting, phase 16 will tell the real story
availability speculation must be flaired Speculation
What are you comparing it against though?
- 1Rodent data is rodent data. Dose scaling is not linear and the models tell…9 comments in this branch · started by u/nils_ferreira